thiophenes has been researched along with ly517717 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hampton, T | 1 |
| Turpie, AG | 1 |
| Harenberg, J; Wehling, M | 1 |
| Perzborn, E | 1 |
2 review(s) available for thiophenes and ly517717
| Article | Year |
|---|---|
Oral, direct factor Xa inhibitors in development for the prevention and treatment of thromboembolic diseases.
Topics: Administration, Oral; Animals; Anticoagulants; Blood Coagulation; Drugs, Investigational; Factor Xa; Factor Xa Inhibitors; Glycine; Humans; Morpholines; Piperazines; Rivaroxaban; Thiophenes; Thromboembolism; Treatment Outcome | 2007 |
Current and future prospects for anticoagulant therapy: inhibitors of factor Xa and factor IIa.
Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Atrial Fibrillation; Azetidines; Benzimidazoles; Benzylamines; Clinical Trials as Topic; Dabigatran; Factor Xa Inhibitors; Glycine; Humans; Infusions, Parenteral; Morpholines; Oligosaccharides; Piperazines; Prothrombin; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes; Thrombin; Thrombosis; Venous Thromboembolism | 2008 |
2 other study(ies) available for thiophenes and ly517717
| Article | Year |
|---|---|
New oral anticoagulants show promise.
Topics: Anticoagulants; Clinical Trials as Topic; Factor Xa Inhibitors; Fondaparinux; Glycine; Humans; Morpholines; Piperazines; Polysaccharides; Rivaroxaban; Thiophenes; Thromboembolism | 2006 |
Factor Xa inhibitors--new anticoagulants for secondary haemostasis.
Topics: Administration, Oral; Anticoagulants; Factor Xa Inhibitors; Glycine; Hemostasis; Humans; Morpholines; Piperazines; Pyrazoles; Pyridones; Pyrrolidines; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2009 |